| 2005 |
| Riedel A., Leopold C.S. Quantification of omeprazole degradation by enteric polymers: an UV-VIS spectroscopy study. Pharmazie 60, 126-130 (2005). |
| Riedel A., Leopold C.S. Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations. Drug Dev. Ind. Pharm. 31, 149–158 (2005). |
| 2006 |
| Stroyer A., McGinity J.W., Leopold C.S. Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers. J. Pharm. Sci. 95, 1342-1353 (2006). |
| Remane Y., Leopold C.S. Transfer of the experimental methodology described in the FDA Guidance for corticosteroid bioequivalence testing to pharmacodynamic effects caused by nicotinates. J. Cosmet. Dermatol. 5, 289-293 (2006). |
| Remane Y., Leopold C.S., Maibach, H.I. Percutaneous penetration of methyl nicotinate from ointments using the Laser Doppler technique: Bioequivalence and enhancer effects. J. Pharmacokin. Pharmacodyn. 33, 719-735 (2006). |
| Remane Y., Leopold C. Time of erythema onset after application of methyl nicotinate ointments as response parameter: Influence of penetration kinetics and enhancing agents. Skin Pharmacol. Physiol. 19, 303-310 (2006). |
| 2007 |
| Leopold C.S. Aktuelles zur Pflastertechnologie unter spezieller Berücksichtigung des Rotigotinpflasters. Akt. Neurol. 34, Suppl. 4, S284-S289 (2007). |
| Schäfer U.F., Lippold B.C., Leopold C.S. Formulation issues; In: Dermal Absorption and Toxicity Assessment (Eds. Roberts M.S., Walters K.A.), 2nd ed., Informa Healthcare, London (2007). |
| 2008 |
| Wiedersberg S., Leopold C.S., Guy R.H. Bioavailability and bioequivalence of topical glucocorticoids. Eur. J. Pharm. Biopharm. 68, 453-466 (2008). |
| 2009 |
| Wiedersberg S., Naik A., Leopold C.S., Guy R.H. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: Assessment of topical bioavailability. Br. J. Dermatol. 160, 676-686 (2009). |
| Wiedersberg S., Leopold C.S., Guy R.H. Dermatopharmacokinetics of betamethasone 17-valerate: Influence of formulation viscosity and skin surface cleaning procedure. Eur. J. Pharm. Biopharm. 71, 362-366 (2009). |
| Wiedersberg S., Leopold C.S., Guy R.H. Effect of various vehicles on skin hydration in vivo. Skin Pharmacol. Physiol. 22, 128-130 (2009). |
| Ploen J., Andersch J., Heschel M., Leopold C.S. Citric acid as pH-modifying additive in an extended release pellet formulation containing a weakly basic drug. Drug Dev. Ind. Pharm. 35, 1210-1218 (2009). |
| Farag
Y., Leopold C.S. Physicochemical properties of various shellac types.
Dissolution Technol. 16, 33-39 (2009). |
| Jost W.H., Leopold
C.S. Grundlagen der Pflasterapplikation von Wirkstoffen beim
Parkinson-Syndrom. Akt. Neurol. 36, Suppl. 4, S1-S6 (2009). |
| 2010 |
| Gasch
J., Oertel R., Leopold C.S., Knoth H. Contamination of 0.2 µm infusion
filters by N,N-dimethylacrylamide. J. Critical Care 25, 172.e9-172.e14 (2010). |
| 2011 |
| Nokhodchi
A., Hentzschel C.M., Leopold C.S. Drug release from liquisolid systems:
speed it up, slow it down. Expert Opin. Drug Deliv. 8, 1-15 (2011). |
| Farag
Y., Leopold C.S. Investigation of drug release from pellets coated with
different shellac types. Drug Dev. Ind. Pharm. 37, 193-200 (2011). |
| Farag
Y., Leopold C.S. Influence of the inlet air temperature in a fluid bed
coating process on drug release from shellac coated pellets. Drug Dev.
Ind. Pharm. 37, 320-328 (2011). |
| Farag
Y., Leopold C.S. Development of shellac-coated sustained release pellet formulations. Eur. J. Pharm. Sci. 42, 400-405 (2011). |
| Hentzschel
C.M., Sakmann, A., Leopold C.S. Suitability of various excipients as
carrier and coating materials for liquisolid compacts. Drug Dev. Ind. Pharm. 37, 1200-1207 (2011). |
| Hentzschel C.M., Sakmann, A., Leopold C.S. Comparison
of traditional and novel tableting excipients – Physical and compaction properties. Pharm. Dev. Technol., DOI:10.3109/10837450.2011.572897 (2011).
|
| Gasch
J., Leopold C.S., Knoth H. Drug retention by inline filters - Effect of positively charged polyethersulfone filter membranes on drug solutions with low concentration. Eur. J. Pharm. Sci. 44, 49-56 (2011). |
Hentzschel C.M., Alnaief
M., Smirnova
I., Sakmann A., Leopold C.S. Enhancement of griseofulvin release from hydrophilic aerogel formulations and liquisolid
compacts. Eur. J. Pharm. Biopharm., DOI:10.1016/j.ejpb.2011.08.001 (2011).
|
Hentzschel C.M., Alnaief
M., Smirnova
I., Sakmann A., Leopold C.S. Tableting properties of silica aerogel and other silicates. Drug Dev. Ind. Pharm. (2011), angenommen.
|
| Alnaief
M., Antonyuk S., Hentzschel C.M., Leopold C.S., Heinrich S., Smirnova
I. A Novel Process for Coating of Silica Aerogel Microspheres for
Controlled Drug Release Applications. Micropor. Mesopor. Mat. (2011), eingereicht.
|
| Farag
Y., Weidner S., Leopold C.S. Mimicking the aging p rocess of shellac by thermal treatment. Pharm. Dev. Technol. (2011),
eingereicht. |
| Rehder S., Klukkert M., Löbmann K. A. M., Strachan C. J., Sakmann A., Gordon K., Rades T., Leopold C. S.
Investigation of the Formation Process of Two Piracetam Cocrystals during Grinding.
Pharmaceutics, 3(4), 706-722 (2011).
|
| Rehder S., Wu J. X., Laackmann J., Moritz H.-U., Rantanen J., Rades T., Leopold C. S.
Real-time monitoring of solid-state phase transformations in acoustically levitated particles using near infrared and Raman spectroscopy, eingereicht
|
| 2012 |
| Rehder
S., Sakmann A., Rades T., Leopold C.S. Thermal degradation of amorphous
glibenclamide. Eur. J. Pharm. Biopharm., 80 (1), 203-208 (2012). |